Pharmaceutical Chemistry of cardiovascular system drugs I Flashcards
1
Q
Renin-angiotensin pathway
Angiotensinogen
A
- Regulate blood volume and electrolytes
- Formed by 452 amino acids
- N- terminal 12 amino acids
2
Q
What does Renin do?
A
- In angiotensinogen at the N-terminus the renin cuts between Leu and Val bond
- formation of 10 chain amino acid Angiotensin I
3
Q
What does Angiotensin converting enzyme do?
A
- Break between Phe and His to formation 8 chain amino acid form Angiotensin II
- This is a potent vasoconstrictor
- Increase peripheral resistance
- Rapid repressor response
4
Q
ACE mechanism
A
- Block synthesis of Angiotensin II inhibit ACE
- Zinc containing exopeptidase break terminal peptide chain
- form ionic bond with carboxylic acid of Leu and protonated amine of ACE
- Zn2+ binds to Phe at peptide bond
- Additional binding at Phe and Leu
- bond Hydrogen on His
- Cut peptide bond Phe and His hydrolysis
5
Q
Captopril
A
- Similar interaction to angiotensin I
- ZN2+ bind to SH
- Ionic bonding with carboxylic acid and protonated amine
- Carbonyl group hydrogen bonding
6
Q
Enalaprilat
A
- Has carboxylic acid ionic bond with 3HN+-ACE
- Zn2+ interaction with carboxylic acid
7
Q
Side effects of Captopril
A
- Causes severe skin rashes
- Taste disturbance
8
Q
Enalaprilat
A
- Zwitterion at physiological pH
- Nitrogen very basic becomes protonated positive charge
- Carboxylic will have negative charge at pH (6-7)
- Low bioavailabity and cannot give orally
- Zinc double interaction with carboxylic acid
9
Q
Enalapril
A
- Instead of the carboxylic acid use of ester
- Neutral charge of NH increase bioavalability when in the intestine as it is an ester
- Less effective than enalaprilat as an ACE inhibitor
- In-vivo changes from enalapril to enalaprilat as it is a prodrug
10
Q
Ramipril
A
- Carboxylic acid to mimic C terminus of angiotensin I
- Large hydrophobic and hydrophobic heterocyclic rings
- Zinc binding group (SH) (COOH) -SH good binding but bad taste and skin rash
- Mimic Phe hydrolysis transition state
- Esterification bioavailability as a prodrug
- Always methyl group
- Stereochemistry must be consistent with L-amino acid
11
Q
Angiotensin II receptor blockers
A
- AT1: Brain, neural, renal, adrenal and myocardial tissue
- 1,000 fold more blocking with AT1 than AT2
12
Q
Losartan
A
- S-8308 weak antagonist mimic weak substrate to improve AT1 receptor binding
13
Q
Structure of losartan
A
- TRY4 Phenol or Asp1 COO of the angiotensin II
- Tetrazole and COOH must be in ortho position for optimal activity
- N-butyl group for hydrophobic binding
-Imidazole ring and different R groups
14
Q
Calcium channel blockers
A
- Increase the amount of Calcium in the inner part of the cell between actin and myosin
- Influx is regulated by operating channels Na/Ca2+ leak pathways
15
Q
Function of Calcium Channel blocker
A
- Block Ca2+ influx by binding on allosteric site